The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it sell, with a mean price target of $990.
Graham Holdings Company
GHC · the NYSE · USD · Market cap $4.8B · 12,747 employees
Graham Holdings Company, through its subsidiaries, operates as a diversified holding company in the United States and internationally.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Graham Holdings Company holds its Markdown at $1,138.57. Consolidating, no directional conviction, held for 157 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 157 days |
| Price at the screen | $1,138.57 |
| Valuation | 9.21 trailing · 16.99 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.71 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 15.76% | Below 33% | Interest-bearing debt is just 15.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 12.97% | Below 33% | Cash held in interest-bearing accounts and securities is 13.0% of assets, under the one-third limit. | Pass |
| Receivables | 9.36% | Below 49% | Money owed to the company is 9.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.17% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 18.4% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEducation Holdings Trade Well Above Fair Value
When families stump up for test prep or career courses, the cash lands inside Graham Holdings diversified education and training arms. The numbers show modest 6% revenue growth, 6% profit margins and 7% return on equity, hardly the profile of a compounder.
The shares sit at 1177 against a fair value of 904, a negative 23% margin of safety, while the forward multiple of 17.6 times already prices in better growth than the business has delivered. The single analyst target of 990 still leaves the stock expensive, and an unknown moat offers no cushion.
Low returns and thin margins leave little room for execution slips or sector pressure, so the valuation gap stays the dominant reason to pass despite the clean ethical screen. Analysis, not advice.
| Forward P/E | 17.0xexpensive even after accounting for its growth |
| Trailing P/E | 9.2xvery cheap relative to earnings |
| EPS, trailing | 123.68 |
| EPS, forward | 67.00 |
| Revenue growth | +7.1%slow but positive growth |
| Profit margin | 10.7%thin but positive margins |
| Return on equity | 11.9%a modest return on shareholder capital |
| FCF yield | 5.55% |
| Dividend yield | 64.00% |
| Debt to equity | 0.30minimal debt: a conservative balance sheet |
| Current ratio | 1.86healthy short-term liquidity |
| Beta | 0.71steadier than the market |
| Short interest, float | 0.10% |
| 52-week range | 929.76 - 1,262.35 |
| Market cap | $4.8B |
| Employees | 12,747 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGHC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it sell, with a mean price target of $990.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it sell, with a mean price target of $990.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,104.03 | +4.2% | · | $1,042 | +4.2% |
| 2 months | $1,100.01 | +4.5% | $1.88 | $1,047 | +4.7% |
| 3 months | $1,044.07 | +10.2% | $1.88 | $1,103 | +10.3% |
| 6 months | $1,110.36 | +3.6% | $3.76 | $1,039 | +3.9% |
| 1 year | $948.41 | +21.3% | $7.36 | $1,220 | +22.0% |
| 2 years | $698.95 | +64.5% | $14.40 | $1,666 | +66.6% |
| 3 years | $560.17 | +105.3% | $21.14 | $2,091 | +109.1% |
| 5 years | $626.64 | +83.5% | $33.78 | $1,889 | +88.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GHC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.